Risk of Coronary Heart Disease in Association with Periodontitis and Periimplantitis
This lecture will introduce new technologies to detect and reduce risk factors: From aMMP8 diagnostic, to biofilm reduction for Implants and anti-inflammatory therapy.
For those of you that attended the live course at the Greater New York Dental meeting, click on the "Take C.E. Quiz" button and answer the question to receive your certificate.
Recent meta analysis reported an association between Periodontal disease (PD) and coronary heart disease (CHD) and show a significant higher risk of 1.14 to 2.22 of developing (CHD). The new chair-side of detection of matrix metalloproteinase MMP8 allows clinicians to monitor periodontal disease status in a site-specific manner and increase the patient compliance to treatment option and relevance to general health and CHD.
The consensus Report of the sixth European Workshop on Periodontology showed that Periimplantitis occurs in 28%-56% of subjects and becomes a major problem to implant dentistry in the future. Current evidence indicates that most of destruction of the periodontium is host mediated, driven by bacterial challenge.
Zirconium nitride hard coating technology for dental implants showed a high significant positive effect on biofilm reduction and fibroblast adhesion and surface mechanical resistance.